Eric M. Lindenfeld
Overview
Eric Lindenfeld is a member of the firm’s Mass Tort Practice Group and focuses his practice on representing public entities as plaintiffs in complex litigation. Eric has played an integral role in litigation around the country, including in Minnesota v. JUUL, which settled favorably in 2023 on the eve of closing arguments. Eric was also a part of the trial and litigation teams in In Re: National Prescription Opiate Litigation, a consolidated suit in the Northern District of Ohio involving the national opioid crisis.
Eric earned his law degree, with honors, from the University of Minnesota. He has authored several scholarly articles in prominent law journals, including in the Yale Journal of Law and Technology and the Food and Drug Law Journal. His publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology, and the Food and Drug Administration casebooks.
In his free time, Eric enjoys hiking, watching documentaries, spending time with his niece and nephew, and of course, watching the Knicks win basketball games.
Practices
Admissions
- Minnesota
- New Jersey
- New York
- U.S. District Court, District of Minnesota
- U.S. District Court, Eastern District of New York
- U.S. District Court, Northern District of New York
- U.S. District Court, Southern District of New York